Nektar Therapeutics (NKTR)
76.24
+1.52
(+2.03%)
USD |
NASDAQ |
Apr 07, 16:00
77.50
+1.26
(+1.65%)
After-Hours: 05:24
Nektar Therapeutics Gross Profit (Annual) : 54.21M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Boston Scientific Corp. | 13.06B |
| Eli Lilly & Co. | 54.13B |
| Soleno Therapeutics, Inc. | 187.70M |
| Regeneron Pharmaceuticals, Inc. | 11.70B |
| Rigel Pharmaceuticals, Inc. | 274.66M |